share_log

硕世生物(688399.SH):尚未开展细胞治疗领域的业务

Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SH): has not yet launched business in the field of cell therapy

Gelonghui Finance ·  Sep 12 11:29

Gelonghui, September 12 | Shuoshi Biotech (688399.SH) said on the investor interactive platform that the company currently focuses on R&D, production and sales of in vitro diagnostic products such as in vitro diagnostic reagents and supporting testing instruments, focusing on the two major fields of disease prevention and control (CDC) and clinical maternal and child testing, and has not yet developed business in the field of cell therapy.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment